Picture of IRIDEX logo

IRIX — IRIDEX News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Iridex Corp Reports Results For The Quarter Ended In December: Earnings Summary

* IRIDEX Corp  IRIX.OQ  reported a quarterly adjusted loss
of 18
cents​​ per share for the quarter ended in December, lower than
the same quarter last year, when the company reported EPS of -7
cents.  The lone analyst forecast for the quarter was for a loss
of 5 cents per share. 
    * Revenue fell 18% to $12.46 million from a year ago;
analysts
expected $14.90 million. 
    * IRIDEX Corp's reported EPS for the quarter was a loss
of 18
cents​.
    * The company reported a quarterly loss of $2.96 million.
    * IRIDEX Corp shares had fallen by 7.8% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for IRIDEX Corp
is
$2.00 

This summary was machine generated from LSEG data March 26 at
09:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.05          -0.18          Missed
 Sep. 30 2023      -0.12          -0.11          Beat
 Jun. 30 2023      -0.11          -0.17          Missed
 Mar. 31 2023      -0.12          -0.13          Missed

Recent news on IRIDEX

See all news